» Articles » PMID: 15194433

FGF2 Inhibits Proliferation and Alters the Cartilage-like Phenotype of RCS Cells

Overview
Journal Exp Cell Res
Specialty Cell Biology
Date 2004 Jun 15
PMID 15194433
Citations 31
Authors
Affiliations
Soon will be listed here.
Abstract

Several forms of human dwarfism are due to activating mutations in FGFR3 highlighting the role of FGF signaling in the growth attenuation of cartilage. Here, we studied the effects of FGF2 on RCS chondrocytes. Treatment with FGF2 induced growth arrest in the G1 phase of the cell cycle and partial de-differentiation of cells manifested by changes in cell morphology, loss of the cartilage-like extracellular matrix, and down-regulation of aggrecan expression. FGF2 activated phospholipase Cgamma, protein kinase B, and Erk and p38 MAP kinases. Chemical inhibition of FGFR3 and MEK1/2 antagonized FGF2-mediated growth arrest. Expression of a dominant-negative Ras mutant resulted in a partial reversal of growth inhibition while expression of constitutively activated Ras led to Erk-dependent growth arrest, further demonstrating the role of the Ras/Erk pathway in this phenotype. At the molecular level, FGF2-induced growth arrest was initiated by disintegration of cyclin D3-cdk6 complex followed by increased association of p21(WAF1) and p27(Kip1) with the cyclin-cdk2 and cyclin-cdk4 complexes leading to inhibition of their kinase activities and ultimately to underphosphorylation of the p107 and p130 pocket proteins. Both p21(WAF1) and p27(Kip1) accumulated upon FGF2 treatment, but this accumulation occurred at the protein level at least partially due to interaction with transcriptionally induced cyclin D1.

Citing Articles

Meclozine and growth hormone ameliorate bone length and quality in experimental models of achondroplasia.

Sawamura K, Matsushita M, Esaki R, Mishima K, Kamiya Y, Ohno K J Bone Miner Metab. 2024; .

PMID: 39514089 DOI: 10.1007/s00774-024-01563-x.


FGF19 induces the cell cycle arrest at G2-phase in chondrocytes.

Chen H, Li J, Pi C, Guo D, Zhang D, Zhou X Cell Death Discov. 2023; 9(1):250.

PMID: 37454120 PMC: 10349815. DOI: 10.1038/s41420-023-01543-6.


MPSI Manifestations and Treatment Outcome: Skeletal Focus.

De Ponti G, Donsante S, Frigeni M, Pievani A, Corsi A, Bernardo M Int J Mol Sci. 2022; 23(19).

PMID: 36232472 PMC: 9569890. DOI: 10.3390/ijms231911168.


Single-cell RNA sequencing reveals PDGFRα+ stromal cell subpopulations that promote proacinar cell differentiation in embryonic salivary gland organoids.

Moskwa N, Mahmood A, Nelson D, Altrieth A, Forni P, Larsen M Development. 2022; 149(6).

PMID: 35224622 PMC: 8977102. DOI: 10.1242/dev.200167.


Meclozine Attenuates the MARK Pathway in Mammalian Chondrocytes and Ameliorates FGF2-Induced Bone Hyperossification in Larval Zebrafish.

Takemoto G, Matsushita M, Okamoto T, Ito T, Matsuura Y, Takashima C Front Cell Dev Biol. 2022; 9:694018.

PMID: 35118060 PMC: 8804316. DOI: 10.3389/fcell.2021.694018.